JPWO2024009977A1 - - Google Patents
Info
- Publication number
- JPWO2024009977A1 JPWO2024009977A1 JP2024532139A JP2024532139A JPWO2024009977A1 JP WO2024009977 A1 JPWO2024009977 A1 JP WO2024009977A1 JP 2024532139 A JP2024532139 A JP 2024532139A JP 2024532139 A JP2024532139 A JP 2024532139A JP WO2024009977 A1 JPWO2024009977 A1 JP WO2024009977A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022108654 | 2022-07-05 | ||
| PCT/JP2023/024703 WO2024009977A1 (ja) | 2022-07-05 | 2023-07-04 | ５Ｈ－ピロロ［２，３－ｄ］ピリミジン－６（７Ｈ）－オン及びその塩体の結晶 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2024009977A1 true JPWO2024009977A1 (enExample) | 2024-01-11 |
Family
ID=89453401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532139A Pending JPWO2024009977A1 (enExample) | 2022-07-05 | 2023-07-04 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20260001883A1 (enExample) |
| EP (1) | EP4553078A1 (enExample) |
| JP (1) | JPWO2024009977A1 (enExample) |
| CN (1) | CN119403807A (enExample) |
| MA (1) | MA71401A (enExample) |
| TW (1) | TW202421127A (enExample) |
| WO (1) | WO2024009977A1 (enExample) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007534687A (ja) * | 2004-04-23 | 2007-11-29 | エグゼリクシス， インコーポレイテッド | キナーゼ調節因子および使用方法 |
| JP2012508274A (ja) * | 2008-11-11 | 2012-04-05 | イーライ リリー アンド カンパニー | Ａｋｔおよびｐ７０ｓ６キナーゼ阻害剤 |
| WO2017200087A1 (ja) * | 2016-05-20 | 2017-11-23 | 大鵬薬品工業株式会社 | 新規５Ｈ－ピロロ［２，３－ｄ］ピリミジン－６（７Ｈ）－オン誘導体 |
-
2023
- 2023-07-04 JP JP2024532139A patent/JPWO2024009977A1/ja active Pending
- 2023-07-04 WO PCT/JP2023/024703 patent/WO2024009977A1/ja not_active Ceased
- 2023-07-04 EP EP23835509.3A patent/EP4553078A1/en active Pending
- 2023-07-04 US US18/880,293 patent/US20260001883A1/en active Pending
- 2023-07-04 TW TW112124881A patent/TW202421127A/zh unknown
- 2023-07-04 MA MA71401A patent/MA71401A/fr unknown
- 2023-07-04 CN CN202380051803.7A patent/CN119403807A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007534687A (ja) * | 2004-04-23 | 2007-11-29 | エグゼリクシス， インコーポレイテッド | キナーゼ調節因子および使用方法 |
| JP2012508274A (ja) * | 2008-11-11 | 2012-04-05 | イーライ リリー アンド カンパニー | Ａｋｔおよびｐ７０ｓ６キナーゼ阻害剤 |
| WO2017200087A1 (ja) * | 2016-05-20 | 2017-11-23 | 大鵬薬品工業株式会社 | 新規５Ｈ－ピロロ［２，３－ｄ］ピリミジン－６（７Ｈ）－オン誘導体 |
Non-Patent Citations (2)
| Title |
|---|
| 平山 令明, 有機化合物結晶作製ハンドブック, JPN6014035600, 2008, pages 17 - 23, ISSN: 0005610294 * |
| 芦澤 一英: "塩・結晶形の最適化と結晶化技術", PHARM TECH JAPAN, vol. 18, no. 10, JPN6013060608, 2002, pages 81 - 96, ISSN: 0005610295 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024009977A1 (ja) | 2024-01-11 |
| TW202421127A (zh) | 2024-06-01 |
| EP4553078A1 (en) | 2025-05-14 |
| MA71401A (fr) | 2025-04-30 |
| CN119403807A (zh) | 2025-02-07 |
| US20260001883A1 (en) | 2026-01-01 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241216 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250603 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250728 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250926 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20251202 |